Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 1;13(4):2352-2363.
doi: 10.21037/qims-22-584. Epub 2023 Feb 16.

11C-methionine PET/CT and conventional imaging techniques in the diagnosis of primary hyperparathyroidism

Affiliations

11C-methionine PET/CT and conventional imaging techniques in the diagnosis of primary hyperparathyroidism

Karina Pogosian et al. Quant Imaging Med Surg. .

Abstract

Background: It is well known that primary hyperparathyroidism (PHPT) is one of the most common endocrine disorders. Precise preoperative adenoma localization is essential for increasing PHPT cure rate. Conventional localization techniques include neck ultrasound, 99m-Tc-sestamibi scintigraphy, and computed tomography (CT). However, all of these methods have limitations. 11C-methionine positron emission tomography/computed tomography (PET/CT) combines both anatomical and functional modalities; it may be useful in terms of lowering the imaging procedures number and improving accuracy.

Methods: A retrospective diagnostic accuracy study with sensitivity and specificity evaluation was conducted. We studied the data of 91 patients with PHPT, who were hospitalized at Almazov National Medical Research Centre. Medical records, lab results, and CT imaging of all patients were analyzed. All of them underwent ultrasound. 99m-Tc-sestamibi/99m-Tc-pertechnetate subtraction scintigraphy and CT were performed on 56 and 86 patients, respectively. Since 2020 11C-methionine PET/CT has been performed on 45 patients. Then, minimally invasive parathyroidectomy (PTX) was carried out in all patients. Histological results were used as a benchmark in order to evaluate diagnostic accuracy of studied methods. Parathyroid adenoma or hyperplasia was confirmed in all patients. Multiple lesions were found in 5 patients. Nineteen lesions were ectopic. All patients with multiple lesions required at least 3 localization techniques, and 2 of them required 4.

Results: The sensitivity of 11C-methionine PET/CT was 98%, CT, 99m-Tc-sestamibi scintigraphy, and ultrasound showed sensitivity at 75%, 79%, and 67%, respectively. The estimated specificities of 11C-methionine PET/CT, CT, 99m-Tc-sestamibi scintigraphy and ultrasound were 93%, 73%, 75%, and 70%, respectively.

Conclusions: Our study showed that 11C-methionine PET/CT has higher sensitivity and specificity than conventional techniques in a group of 19 patients. 11C-methionine PET/CT may take a place in the imaging of parathyroid adenomas, it may replace CT and 99m-Tc-sestamibi scintigraphy while simultaneously providing information about lesion topography and function.

Keywords: 11C-methionine; Positron emission tomography/computed tomography (PET/CT); computed tomography (CT); primary hyperparathyroidism (PHPT); scintigraphy.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://qims.amegroups.com/article/view/10.21037/qims-22-584/coif). The authors report that this work was financially supported by the Ministry of Science and Higher Education of the Russian Federation (No. 075-15-2022-301). The authors have no other conflicts of interest to declare.

Figures

Figure 1
Figure 1
Parathyroid adenoma localization techniques. PHPT, primary hyperparathyroidism; CT, computed tomography; PET/CT, positron emission tomography/computed tomography; TP, true positive; FP, false positive; TN, true negative; FN, false negative.
Figure 2
Figure 2
11C-methionine PET/CT results in a 41-year-old female showed an intrathyroid lesion from the right thyroid gland (white arrows) and a lesion corresponding to left lower parathyroid adenoma (white arrowheads). Those appeared to be double hyperplasia according to histology result. PET/CT, positron emission tomography/computed tomography.
Figure 3
Figure 3
Discordant US results and positive 11C-methionine PET/CT results in a 66-year-old female. (A) US showed 3 lesions (white arrows). The left one (A) was located at the lower pole of the left thyroid gland back side. The lesion in the middle (A) borders with the first one and, presumably, comes out from the lower pole of the left thyroid gland, and descends to the retrosternal region. The right one (A) was located in the middle of the right thyroid gland back side. All of them were suspected to be parathyroid adenomas. (B) However, 11C-methionine PET/CT (B) showed only one focus of high 11C-methionine uptake in a lesion located at the back side of left thyroid gland (white arrows). A retrosternal lesion is showed by white arrowheads. (C) 11C-methionine PET/CT of the lesion from the right thyroid gland back side is showed by black arrowheads, and a focus of high 11C-methionine uptake in a lesion located at the back side of left thyroid gland is showed by white arrows. According to histology results, only the lower left lesion was a parathyroid adenoma. The retrosternal lesion appeared to be a multinodular goiter. The lesion from the right thyroid gland back side was normal thyroid tissue. US, ultrasound; PET/CT, positron emission tomography/computed tomography.

References

    1. Noltes ME, Coester AM, van der Horst-Schrivers ANA, Dorgelo B, Jansen L, Noordzij W, Lemstra C, Brouwers AH, Kruijff S. Localization of parathyroid adenomas using (11)C-methionine pet after prior inconclusive imaging. Langenbecks Arch Surg 2017;402:1109-17. 10.1007/s00423-017-1549-x - DOI - PMC - PubMed
    1. Walker MD, Bilezikian JP. Primary Hyperparathyroidism. Endotext [Internet]. South Dartmouth (MA); 2021 [updated 2021 Apr 19, cited 2022 Mar 28]. Available online: https://www.ncbi.nlm.nih.gov/books/NBK278923/
    1. Khan AA, Hanley DA, Rizzoli R, Bollerslev J, Young JE, Rejnmark L, et al. Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos Int 2017;28:1-19. 10.1007/s00198-016-3716-2 - DOI - PMC - PubMed
    1. Cheung K, Wang TS, Farrokhyar F, Roman SA, Sosa JA. A meta-analysis of preoperative localization techniques for patients with primary hyperparathyroidism. Ann Surg Oncol 2012;19:577-83. 10.1245/s10434-011-1870-5 - DOI - PubMed
    1. Kunstman JW, Kirsch JD, Mahajan A, Udelsman R. Clinical review: Parathyroid localization and implications for clinical management. J Clin Endocrinol Metab 2013;98:902-12. 10.1210/jc.2012-3168 - DOI - PubMed